ln18 cells Search Results


90
National Centre for Cell Science ln-229, human glioblastoma epithelial cells
Ln 229, Human Glioblastoma Epithelial Cells, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ln-229, human glioblastoma epithelial cells/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
ln-229, human glioblastoma epithelial cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
InVivos Pte Ltd idh-mutant ln18-luc cells
Idh Mutant Ln18 Luc Cells, supplied by InVivos Pte Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/idh-mutant ln18-luc cells/product/InVivos Pte Ltd
Average 90 stars, based on 1 article reviews
idh-mutant ln18-luc cells - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Institute for Clinical Pharmacodynamics glioma cell line u87mg p53si
Glioma Cell Line U87mg P53si, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glioma cell line u87mg p53si/product/Institute for Clinical Pharmacodynamics
Average 90 stars, based on 1 article reviews
glioma cell line u87mg p53si - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Corning Life Sciences ln18 cell line
Analysis of cell proliferation and invasion in GB cells with RNF123-OV. ( A ) A172, <t>HS683,</t> and LN18 cell lines were stably transfected with empty vector (EV1) or a cDNA encoding Myc- RNF123 (RNF123-OV). RNF123-OV and p50 were assessed by Western blot, and β-actin was used as a loading control. ( B ) Quantification of RNF123 expression by RT-qPCR ( t -test, *** p < 0.001). ( C , D ) Proliferation of LN18 (C) and A172 (D) cell lines with RNF123-OV or the empty vector (EV1) (two-way ANOVA, Bonferroni correction *** p < 0.001). ( E , F ) Colony-forming units LN18 (E) and A172 (F) cell lines stably expressing control empty vector 1 (EV1) or RNF123-OV ( t -test, *** p < 0.001). ( G , H ) Percentage of invasion in LN18 (G) and A172 (H) cell lines stably expressing control (EV1) or RNF123-OV ( t -test, * p < 0.05, ** p < 0.01). ( I ) LN18 cell lines expressing control vector (EV1) or RNF123-OV were analyzed by RNA-sequencing to determine differentially expressed (DE) genes in RNF123-OV cell lines. The image shows a heatmap of the most DE genes (adjusted p < 0.05). ( J ) LN18 (RPPA1) and HS683 (RPPA2) cell lines with RNF123-OV were analyzed by RPPA. The image shows a heatmap of the most DE genes in RNF123-OV cell lines (adjusted p < 0.05). ( K ) Integration of DE genes identified in RPPA1 (LN18), RPPA2 (HS683), and RNA-sequencing in RNF123-OV cell lines that are targets of the NF-κB pathway. ( L ) RT-qPCR for SERPINE1 in A172, HS683, and LN18 cell lines expressing EV1 or RNF123-OV ( t -test, *** p < 0.001). ( M ) Western blot for SerpinE1 in A172, HS683, and LN18 cell lines expressing EV1 or RNF123-OV; low (L) and high (H) exposure times for the same image are shown. ( N ) Correlation analysis of RNF123 and SERPINE1 expression using the TCGA dataset from GB tumors ( n = 145; Spearman’s r = −0.27, p < 0.001). Error bars represent the mean ± SD from n = 3 replicates.
Ln18 Cell Line, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ln18 cell line/product/Corning Life Sciences
Average 90 stars, based on 1 article reviews
ln18 cell line - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier


Image Search Results


Analysis of cell proliferation and invasion in GB cells with RNF123-OV. ( A ) A172, HS683, and LN18 cell lines were stably transfected with empty vector (EV1) or a cDNA encoding Myc- RNF123 (RNF123-OV). RNF123-OV and p50 were assessed by Western blot, and β-actin was used as a loading control. ( B ) Quantification of RNF123 expression by RT-qPCR ( t -test, *** p < 0.001). ( C , D ) Proliferation of LN18 (C) and A172 (D) cell lines with RNF123-OV or the empty vector (EV1) (two-way ANOVA, Bonferroni correction *** p < 0.001). ( E , F ) Colony-forming units LN18 (E) and A172 (F) cell lines stably expressing control empty vector 1 (EV1) or RNF123-OV ( t -test, *** p < 0.001). ( G , H ) Percentage of invasion in LN18 (G) and A172 (H) cell lines stably expressing control (EV1) or RNF123-OV ( t -test, * p < 0.05, ** p < 0.01). ( I ) LN18 cell lines expressing control vector (EV1) or RNF123-OV were analyzed by RNA-sequencing to determine differentially expressed (DE) genes in RNF123-OV cell lines. The image shows a heatmap of the most DE genes (adjusted p < 0.05). ( J ) LN18 (RPPA1) and HS683 (RPPA2) cell lines with RNF123-OV were analyzed by RPPA. The image shows a heatmap of the most DE genes in RNF123-OV cell lines (adjusted p < 0.05). ( K ) Integration of DE genes identified in RPPA1 (LN18), RPPA2 (HS683), and RNA-sequencing in RNF123-OV cell lines that are targets of the NF-κB pathway. ( L ) RT-qPCR for SERPINE1 in A172, HS683, and LN18 cell lines expressing EV1 or RNF123-OV ( t -test, *** p < 0.001). ( M ) Western blot for SerpinE1 in A172, HS683, and LN18 cell lines expressing EV1 or RNF123-OV; low (L) and high (H) exposure times for the same image are shown. ( N ) Correlation analysis of RNF123 and SERPINE1 expression using the TCGA dataset from GB tumors ( n = 145; Spearman’s r = −0.27, p < 0.001). Error bars represent the mean ± SD from n = 3 replicates.

Journal: Cancers

Article Title: Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors

doi: 10.3390/cancers12051081

Figure Lengend Snippet: Analysis of cell proliferation and invasion in GB cells with RNF123-OV. ( A ) A172, HS683, and LN18 cell lines were stably transfected with empty vector (EV1) or a cDNA encoding Myc- RNF123 (RNF123-OV). RNF123-OV and p50 were assessed by Western blot, and β-actin was used as a loading control. ( B ) Quantification of RNF123 expression by RT-qPCR ( t -test, *** p < 0.001). ( C , D ) Proliferation of LN18 (C) and A172 (D) cell lines with RNF123-OV or the empty vector (EV1) (two-way ANOVA, Bonferroni correction *** p < 0.001). ( E , F ) Colony-forming units LN18 (E) and A172 (F) cell lines stably expressing control empty vector 1 (EV1) or RNF123-OV ( t -test, *** p < 0.001). ( G , H ) Percentage of invasion in LN18 (G) and A172 (H) cell lines stably expressing control (EV1) or RNF123-OV ( t -test, * p < 0.05, ** p < 0.01). ( I ) LN18 cell lines expressing control vector (EV1) or RNF123-OV were analyzed by RNA-sequencing to determine differentially expressed (DE) genes in RNF123-OV cell lines. The image shows a heatmap of the most DE genes (adjusted p < 0.05). ( J ) LN18 (RPPA1) and HS683 (RPPA2) cell lines with RNF123-OV were analyzed by RPPA. The image shows a heatmap of the most DE genes in RNF123-OV cell lines (adjusted p < 0.05). ( K ) Integration of DE genes identified in RPPA1 (LN18), RPPA2 (HS683), and RNA-sequencing in RNF123-OV cell lines that are targets of the NF-κB pathway. ( L ) RT-qPCR for SERPINE1 in A172, HS683, and LN18 cell lines expressing EV1 or RNF123-OV ( t -test, *** p < 0.001). ( M ) Western blot for SerpinE1 in A172, HS683, and LN18 cell lines expressing EV1 or RNF123-OV; low (L) and high (H) exposure times for the same image are shown. ( N ) Correlation analysis of RNF123 and SERPINE1 expression using the TCGA dataset from GB tumors ( n = 145; Spearman’s r = −0.27, p < 0.001). Error bars represent the mean ± SD from n = 3 replicates.

Article Snippet: To establish RNF123 overexpressing clones, LN18, A172, and HS683 cell lines (5 × 10 5 cells in 60 mm dishes) (Corning, NY, USA) were transfected with Myc-tagged RNF123 vector (OriGene, Rockville, MD) using the jetPRIME transfection reagent.

Techniques: Stable Transfection, Transfection, Plasmid Preparation, Western Blot, Control, Expressing, Quantitative RT-PCR, RNA Sequencing

MiR-155-5p decreased RNF123 expression and gave a poor prognosis in GB patients. ( A ) TCGA analysis of a merged cohort of low-grade glioma and GB for copy number variations and mutations. The frequency of RNF123 alteration is 0.8% of a total of 1084 patients. ( B ) Correlation analysis of miR-155-5p and RNF123 expression using TCGA dataset from GB tumors ( n = 145; Pearson r = −0.277, p = 0.0007). ( C ) TCGA database analysis of miR-155 in GB tissue ( n = 202) compared to normal brain tissue ( n = 11) ( t -test, *** p < 0.001). ( D ) Rembrandt database analysis of miR-155 expression in GB tissue ( n = 214) compared to normal brain tissue ( n = 21) ( t -test, *** p < 0.001). ( E ) TCGA database analysis of RNA-sequencing data for miR-155 in IDH WT ( n = 145) or mutated ( n = 8) GB tissue compared to normal brain tissue ( n = 5) (one-way ANOVA, *** p < 0.001, NS = non-significant). ( F ) LN18, A172, and HS683 cell lines were transfected with pre-miR-155-5p (miR-155-5p-OV) or miR control (miR-Ctrl) and RNF123 expression was quantified by Western blot. ( G ) miR-155-5p sequence aligned with human RNF123 WT 3′-UTR (WT) and RNF123 Mutant 3′-UTR (Mut) sequences. ( H ) Luciferase reporter activity assay to determine the effect of miR-155-5p on 3′-UTR of RNF123 using human RNF123 3′-UTR (WT) and RNF123 Mutant 3′-UTR (Mut) sequences cloned in RenSP vector ( t -test, NS = non-significant, *** p < 0.001). ( I ) Percentage of invasion of LN18 cell lines with miR-155-5p-OV, RNF123-OV, or both compared to control cell lines (one-way ANOVA, * p < 0.05, NS = non-significant). ( J ) Correlation analysis of miR-155-5p and SERPINE1 expression using TCGA dataset from GB tumors ( n = 145; Pearson r = 0.368, p < 0.0001). ( K ) GB patients from the TCGA database were split into low ( n = 90) and high ( n = 90) miR-155-5p expression and analyzed for RNF123 expression ( t -test, * p < 0.05). ( L ) Kaplan–Meier curves for the OS of GB patients expressing low ( n = 87) versus high ( n = 87) miR-155-5p (log-rank test, p = 0.024). ( M ) Dot plot to determine miR-155-5p expression in pre-operative plasma from GB patients ( n = 19) and plasma of healthy controls ( n = 46) ( t -test, ** p = 0.024). Error bars represent mean ± SD from replicates ( n = 3).

Journal: Cancers

Article Title: Downregulation of the Ubiquitin-E3 Ligase RNF123 Promotes Upregulation of the NF-κB1 Target SerpinE1 in Aggressive Glioblastoma Tumors

doi: 10.3390/cancers12051081

Figure Lengend Snippet: MiR-155-5p decreased RNF123 expression and gave a poor prognosis in GB patients. ( A ) TCGA analysis of a merged cohort of low-grade glioma and GB for copy number variations and mutations. The frequency of RNF123 alteration is 0.8% of a total of 1084 patients. ( B ) Correlation analysis of miR-155-5p and RNF123 expression using TCGA dataset from GB tumors ( n = 145; Pearson r = −0.277, p = 0.0007). ( C ) TCGA database analysis of miR-155 in GB tissue ( n = 202) compared to normal brain tissue ( n = 11) ( t -test, *** p < 0.001). ( D ) Rembrandt database analysis of miR-155 expression in GB tissue ( n = 214) compared to normal brain tissue ( n = 21) ( t -test, *** p < 0.001). ( E ) TCGA database analysis of RNA-sequencing data for miR-155 in IDH WT ( n = 145) or mutated ( n = 8) GB tissue compared to normal brain tissue ( n = 5) (one-way ANOVA, *** p < 0.001, NS = non-significant). ( F ) LN18, A172, and HS683 cell lines were transfected with pre-miR-155-5p (miR-155-5p-OV) or miR control (miR-Ctrl) and RNF123 expression was quantified by Western blot. ( G ) miR-155-5p sequence aligned with human RNF123 WT 3′-UTR (WT) and RNF123 Mutant 3′-UTR (Mut) sequences. ( H ) Luciferase reporter activity assay to determine the effect of miR-155-5p on 3′-UTR of RNF123 using human RNF123 3′-UTR (WT) and RNF123 Mutant 3′-UTR (Mut) sequences cloned in RenSP vector ( t -test, NS = non-significant, *** p < 0.001). ( I ) Percentage of invasion of LN18 cell lines with miR-155-5p-OV, RNF123-OV, or both compared to control cell lines (one-way ANOVA, * p < 0.05, NS = non-significant). ( J ) Correlation analysis of miR-155-5p and SERPINE1 expression using TCGA dataset from GB tumors ( n = 145; Pearson r = 0.368, p < 0.0001). ( K ) GB patients from the TCGA database were split into low ( n = 90) and high ( n = 90) miR-155-5p expression and analyzed for RNF123 expression ( t -test, * p < 0.05). ( L ) Kaplan–Meier curves for the OS of GB patients expressing low ( n = 87) versus high ( n = 87) miR-155-5p (log-rank test, p = 0.024). ( M ) Dot plot to determine miR-155-5p expression in pre-operative plasma from GB patients ( n = 19) and plasma of healthy controls ( n = 46) ( t -test, ** p = 0.024). Error bars represent mean ± SD from replicates ( n = 3).

Article Snippet: To establish RNF123 overexpressing clones, LN18, A172, and HS683 cell lines (5 × 10 5 cells in 60 mm dishes) (Corning, NY, USA) were transfected with Myc-tagged RNF123 vector (OriGene, Rockville, MD) using the jetPRIME transfection reagent.

Techniques: Expressing, RNA Sequencing, Transfection, Control, Western Blot, Sequencing, Mutagenesis, Luciferase, Activity Assay, Clone Assay, Plasmid Preparation, Clinical Proteomics